DoH: MenC vaccine

In summary, these changes are:

  • the removal of the 2nd dose at age 16 weeks from the routine schedule for infants
  • the introduction of an adolescent booster dose at around 14 years

This resource does not cover the actual administration techniques involved in vaccination against MenC. Information on immunisation by nurses and other health professionals is available fromĀ Immunisation against infectious disease, Green Book.

Studies show that vaccination against meningococcal C (MenC) disease in early childhood provides a relatively short-term protective immune response. Protection given by vaccination at 12 months wanes by the teenage years, but vaccination later in childhood provides higher levels of antibody that persist for longer.

This document summarises the changes to the schedule, and addresses likely technical questions about making the changes work in practice.